Chemical Compound

Spinosyn A 17-pseudoaglycone

CAS Registry Number 131929-68-5
Spinosyn A 17-pseudoaglycone chemical structure
Primary Record

Spinosyn A 17-pseudoaglycone

Note: Only for scientific research or as raw materials for production.

In stock
8,074 g
Purity
99.0 %
CAS
131929-68-5

Compound Identifiers & Properties

CAS
131929-68-5
PubChem CID
11767113
SMILES
CC[C@H]1CCC[C@@H]([C@H](C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3[C@@H]2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O
Canonical SMILES
CC[C@H]1CCC[C@H](O)[C@@H](C)C(=O)C2=C[C@@H]3[C@@H](C=C[C@@H]4C[C@@H](O[C@@H]5O[C@@H](C)[C@H](OC)[C@@H](OC)[C@H]5OC)C[C@@H]34)[C@@H]2CC(=O)O1

Names & Synonyms

  • Spinosyn A 17-pseudoaglycone
  • A83543A pseudoglycone
  • FQQ4D6T7VD
  • A 83543A pseudoglycone
  • A-83543A pseudoglycone
  • Spinosyn A reverse pseudoaglycone
  • 131929-68-5
  • KSCLXDPNSMLYPU-YDZPRSSASA-N
  • DTXSID001029382
  • C33H50O9
  • BBF-04289
  • CID11767113
  • CID 11767113
  • HY-135472
  • J1.705.091E
  • (1S,2R,5S,7R,9R,10S,14R,15S,19S)-19-Ethyl-15-hydroxy-14-methyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
  • 2',3',4'-O-methyl-rhamnosyl tetracyclic spinosyn pseudoaglycone
  • (1S,2R,5S,7R,9R,10S,14R,15S,19S)-19-ethyl-15-hydroxy-14-methyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyl-tetrahydropyran-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione
  • (2R)-2alpha-[(2-O,3-O,4-O-Trimethyl-6-deoxy-alpha-L-mannopyranosyl)oxy]-1,2,3,3aalpha,5aalpha,6,8aalpha,8bbeta-octahydro-7,6alpha-[[(2R,3S,7S)-2-methyl-7-ethyl-1,9-dioxo-3-hydroxy-8-oxadecane]-1,10-diyl]-as-indacene
  • (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-[(6-Deoxy-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy]-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-13-hydroxy-14-methyl-1H-as-indaceno[3,2-d]oxacyclododecin-7,15-dione
  • (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-9-ethyl-13-hydroxy-14-methyl-2-{[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy}-1H,2H,3H,3aH,5aH,5bH,6H,7H,9H,10H,11H,12H,13H,14H,15H,16aH,16bH-as-indaceno[3,2-d]oxacyclododecane-7,15-dione
  • (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-9-ethyl-13-hydroxy-14-methyl-2-{[(3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy}-1H,2H,3H,3aH,5aH,5bH,6H,7H,9H,10H,11H,12H,13H,14H,15H,16aH,16bH-as-indaceno[3,2-d]oxacyclododecane-7,15-dione
  • 1alpha,2beta-[(R)-2-(2-O,3-O,4-O-Trimethyl-alpha-L-rhamnopyranosyloxy)propane-1,3-diyl]-8beta-ethyl-12alpha-hydroxy-13beta-methyl-1,2,4aalpha,4bbeta,8,9,10,11,12,13-decahydro-7-oxa-7H-cyclododeca[a]indene-6,14(5H,15aalphaH)-dione
  • 1H-as-Indaceno[3,2-d]oxacyclododecin-7,15-dione, 2-[(6-deoxy-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy]-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-13-hydroxy-14-methyl-, (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-
  • 9-ethyl-13-hydroxy-14-methyl-2-(3,4,5-trimethoxy-6-methyltetrahydro-2H- pyran-2-yloxy)-3,3a,5b,6,9,10,11,12,13,14,16a,16b-dodecahydro-1H- as-indaceno[3,2-d][1]oxacyclododecine-7,15(2H,5aH)- dione
  • N/A